Meibomian Gland Dysfunction
Meibomian Gland Dysfunction are the tiny oil glands present on the margin of the eyelids (the edges which touch when the eyelids are closed). These glands secrete oil which coats the surface of our eyes and keeps the water component of our tears from evaporating (drying out).
Meibomian gland dysfunction (MGD) refers to a condition where the Meibomian glands do not secrete enough oil or the oil they secrete is of poor quality. This causes because, the oil gland openings gets plugged up so that less oil comes out of the glands. The oil that does make it out of the glands can be granular (crusty) or otherwise abnormal, and can cause irritation. The increase in Meibomian Gland Dysfunction market share is a direct consequence of increasing prevalent population and awareness of MGD patients in the 7MM. Along with these, development of advanced technologies will also give a robust growth to the market.
In the early stages, patients are often asymptomatic, but if left untreated, patients may develop several symptoms like dryness, burning, itching, stickiness, watering eyes, red eyes, etc. Treatments for Meibomian gland dysfunction typically includes, applying warm compresses to the eyelids, followed by massaging the eyelids. The goal of this treatment was to melt and express any thickened oil clogging the openings of Meibomian glands. However, several new treatment options are present now such as, The LipiFlow thermal pulsation system, iLUX, TearCare, Intense pulsed light (IPL), Blephex, Lid debridement, Antibacterial and Cyclosporin eye drops and the Omega-3 supplements.
The doctors may use devices that send heat or pulsed light to open blocked Meibomian glands and improve symptoms. Some opticians will recommend a combination of treatments for MGD and dry eyes.
Comments
Post a Comment